Earth Science Tech, Inc.OTC: ETST

Earth Science Tech, Inc. (ETST) Reports Third Fiscal Quarter 2026 Results

· Issued by Earth Science Tech, Inc. via GlobeNewswire
  • Revenue of $8.4 million, up 14.1% year-over-year

  • Gross profit margin of 76.3%, up 71 bps year-over-year

  • Net income of $910,000, up 341% year-over-year

  • Generated positive cash from operations of $1.2 million fiscal year-to-date

  • Peaks, the company’s telemedicine platform, surpasses $2.0 million in revenue in less than a year, scaling from $248,000 into a high‑margin growth platform

  • Reduced outstanding shares of common stock by 3.6% year over year through share repurchases

  • Geographic expansion underway with up to 10 additional state licenses pending

  • Strong calendar 2026 performance signals positive trajectory for fiscal Q4

MIAMI, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential operating businesses, today announced its financial and operational results for the third fiscal quarter ended December 31, 2025.

“We exited the third fiscal quarter with strong strategic momentum and continued progress across our diversified platform,” said Giorgio R. Saumat, CEO and Chairman of the Board of Earth Science Tech, Inc. “Results were largely consistent with the prior quarter and reflected typical seasonality, including holiday timing and temporary macro and supply-related headwinds. Importantly, multiple operating units are now generating positive cash flow, underscoring the strength and resilience of our portfolio approach.”

Mr. Saumat continued, “While our reported results reflect the current stage of our growth and investment cycle, they do not yet fully capture the operating leverage inherent in the model. Moving ahead, we see a clear and verifiable path to a materially higher earnings baseline through expense rationalization and scale, a view reinforced by our ongoing share repurchases and my long‑term ownership position acquired entirely with cash. With calendar 2026 off to a strong start and several geographic and product expansion initiatives underway, we believe the Company is well positioned for accelerating growth in the periods ahead.”

Fiscal Q3 2026 Key Financial Highlights

  • Revenue of $8.4 million, up 14.1% compared to $7.4 million for the three months ended December 31, 2024

  • Gross profit of $6.4 million, or a gross margin of 76.3%, as compared to $5.1 million or a gross margin of 69.2%, for the three months ended December 31, 2024, an increase of $1.3 million, or 25.8% on a dollar basis

  • Net Income of $910,000, up 341.0% compared to $206,000 for the three months ended December 31, 2024

  • Total Assets of $8.1 million, up 14.5% compared to $7.1 million at March 31, 2025

  • Repurchased and retired 3,703,296 shares of common stock for the nine months ended December 31, 2025

Third Fiscal Quarter 2026 Financial Results

Revenue

Revenue for the three months ended December 31, 2025, was $8.4 million, an increase of 14%, as compared to $7.4 million during the third quarter of last year primarily due to an increase in product sales.

Gross Profit/Margin

Gross profit for the third quarter of fiscal 2026 was $6.4 million, or a 76.3% gross margin, compared to gross profit of $5.1 million, or a 69.2% gross margin, for the same period in 2024. The increase in gross profit was primarily attributable to higher product sales, with incremental volume contributing to improved operating leverage and margin expansion.

Operating Expenses

For the three months ended December 31, 2025, operating expenses were $5.1 million as compared to $4.9 million for the same period in 2024. The increase in operating expenses was primarily the result of an increase in advertising and marketing and office/selling, general and administrative expenses, which were partially offset by a decrease in salaries expense.

Net Income

Net income was $910,000, or $0.003 per diluted share, for the three months ended December 31, 2025, as compared to $206,000, or $0.001 for the same period in 2024.

Adjusted EBITDA

Adjusted EBITDA was $1.2 million for the three months ended December 31, 2025, as compared to $0.3 million for the same period in 2024.

Balance Sheet

As of December 31, 2025, the Company had $416,000 of cash on hand and working capital of $773,000, compared to $1.5 million of cash on hand and working capital of ($36,000) as of March 31, 2025. The decrease in cash on hand is primarily due to investments in inventory to support higher sales volumes and improve product availability, as well as increased operating activity during the period. The Company had no bank debt as of December 31, 2025.

The Company repurchased and retired 1,143,000 and 3,703,296 shares of its common stock for the three and nine months ended December 31, 2025, respectively.

Conference Call and Webcast:

The Company will host a conference call and webcast to discuss its second fiscal quarter results, highlights, and outlook at 5:00 Eastern Time. To participate in the telephone conference call please dial in at least 15 minutes prior to start time.

Conference Call Information

Date: Tuesday, February 17, 2026
Time: 5 p.m. Eastern Time
Toll Free: 1 800-450-7155 Code: 9041018#
International: +1 857-999-9155 Code: 9041018#
Live Webcast Link: https://www.cstproxy.com/earthsciencetech/earnings/2025/q3/

Conference Call Replay Information

Replay Webcast Link: https://www.cstproxy.com/earthsciencetech/earnings/2025/q3/

Non-GAAP Measures

In addition to disclosing financial results in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), this document references certain non-GAAP financial measures. The Company defines Adjusted EBITDA as earnings excluding interest, tax, depreciation and amortization. We believe these non-GAAP financial measures provide investors with useful supplemental information about our operating performance and enable comparison of financial trends and results between periods where certain items may vary, independent of business performance.

Please refer to “Reconciliation of Non-GAAP Measures” in this document for a detailed explanation of the adjustments made to the comparable U.S. GAAP measures.

About Earth Science Tech, Inc. (ETST)

Earth Science Tech, Inc. is a diversified holding company focused on the health and wellness sector. Through its wholly-owned subsidiaries, ETST operates a vertically integrated portfolio that includes high-quality compounding pharmacies, telemedicine platforms, and targeted healthcare facilities. The Company currently owns RxCompoundStore.com and Mister Meds, two licensed compounding pharmacies providing sterile and non-sterile medications across a growing network of U.S. states. These operations are supported by Peaks Curative, DOConsultation.com, and Las Villas Health Care, providing patients with personalized care, telemedicine connectivity, and clinical support.

Beyond healthcare, ETST manages Avenvi, its real estate and asset management arm, and 80% of MagneChef, a direct-to-consumer brand leveraging proprietary IP for innovative kitchen products. The Company is also committed to social responsibility through the Earth Science Foundation, a non-profit dedicated to assisting patients with prescription costs.

To learn more, please visit: www.EarthScienceTech.com

Forward-Looking Statements

Except for historical information, the matters discussed herein may be considered “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.

Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including, without limitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on and reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions, as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking words such as “expect,” “expectation,” “believe,” “anticipate,” “may,” “could,” “intend,” “belief,” “plan,” “estimate,” “target,” “predict,” “likely,” “seek,” “project,” “model,” “ongoing,” “will,” “should,” “forecast,” “outlook” or similar terminology. Forward-looking statements are subject to a number of risks and uncertainties that may cause the Company’s actual results to differ materially from our intent, belief or current expectations, including, inter alia, the markets for the Company’s products and services, costs of goods and services, other expenses, government regulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.

Contact:

Hayden IR

James Carbonara
(646)-755-7412
james@haydenir.com

Brett Maas
(646) 536-7331
brett@haydenir.com

-- Tables Follow --

Earth Science Tech, Inc. and Subsidiaries
Consolidated Balance Sheets
(Unaudited)

As of
December 31, 2025

As of
March 31, 2025

ASSETS

Current Assets:

Cash and cash equivalents

$

415,699

$

1,473,228

Accounts Receivable

306,118

129,064

Equity Investments at fair value

1,126,307

645,438

Inventory

1,088,019

503,938

Deposits

57,631

338,108

Prepaid

39,159

20,730

Total current assets

3,032,933

3,110,505

Non-Current Assets:

Property and Equipment, net

1,890,801

1,384,110

Right of use asset, net

139,231

172,429

Goodwill

2,648,788

2,302,792

Intangible Assets, net

377,684

96,885

Total Assets

$

8,089,437

$

7,066,721

LIABILITIES AND EQUITY

Accounts payable

$

1,088,521

$

492,352

Accrued expenses and other payable

1,019,036

2,322,022

Current portion of operating lease obligations

121,851

121,851

Current portion of equipment loan

30,592

30,592

Short-term business loan

-

179,488

Total Current Liabilities

2,260,000

3,146,305

Long-Term Liabilities:

Lease liability less current maturities

18,177

37,878

Equipment loan, non-current

8,254

31,427

Total Liabilities

2,286,431

3,215,610

Commitment and Contingencies (Note 11)

Stockholders’ Equity:

Preferred stock, par value $0.001 per share, 1,000,000 shares authorized; 1,000,000 and 0 shares issued and outstanding as of December 31, 2025, and March 31, 2025, respectively

1,000

1,000

Common stock, par value $0.001 per share, 300,000,000 shares authorized; 291,644,607 issued and 291,609,607 outstanding, and 295,347,903 issue and 294,302,607 outstanding as of December 31, 2025, and March 31, 2025, respectively

291,644

295,348

Additional paid-in capital

30,836,759

31,480,143

Accumulated deficit

(25,396,738

)

(27,738,975

)

Treasury Stock, at cost 35,000 and 1,045,296 shares as of December 31, 2025, and March 31, 2025, respectively

(5,525

)

(186,404

)

Non-Controlling Interest

75,866

-

Total stockholders’ Equity

5,803,006

3,851,111

Total Liabilities and Equity

$

8,089,437

$

7,066,721


Earth Science Tech, Inc. and Subsidiaries

Consolidated Statements of Operations
For Three and Nine months ended December 31, 2025, and 2024
(Unaudited)

For the Three Months Ended
December 31,

For the Nine Months Ended
December 31,

2025

2024

2025

2024

Revenue

$

8,386,779

7,352,635

$

26,197,596

$

24,440,600

Cost of Goods Sold

1,987,769

2,265,762

6,983,827

6,676,612

Gross Profit

6,399,010

5,086,873

19,213,769

17,763,988

Expenses

Salaries Expense

2,931,244

3,297,826

10,787,357

10,372,308

Office/Selling, General and Administrative Expenses

914,029

809,850

2,741,912

3,455,474

Advertising & marketing

708,511

346,109

2,082,463

511,455

Bank charges

250,332

210,549

725,340

770,849

Legal & Professional Fees

56,022

61,540

138,141

243,245

Insurance

40,318

79,569

126,863

160,395

Depreciation and Amortization

121,790

44,778

342,751

108,201

Utilities

34,743

10,426

102,769

21,257

Total Expenses

5,056,988

4,860,647

17,047,597

15,643,184

Other Income/Expenses

Dividend Income

4,537

9,123

13,944

9,123

Interest earned

457

16

2,259

13,216

Net realized gain on sale of investments

309,807

174,613

536,951

174,613

Unrealized Gain/Loss of fair value changes of investments

(613,741

)

(197,277

)

(262,067

)

(197,277

)

Interest Expenses

(4,769

)

(6,290

)

(16,335

)

(11,097

)

Net Income before taxes

1,038,314

206,411

2,440,925

2,109,382

Income Tax

127,946

-

127,946

28,349

Net Income

910,367

206,411

2,312,978

2081,033

Net Income/(Loss) attributed to non-controlling interest

(9

)

-

(29,250

)

-

Net Income attributed to shareholders

910,376

206,411

2,342,237

2,081,382

Net Income per common share-Basic and Diluted

0.003

0.001

0.008

0.007

Weighted average number of common shares outstanding basic and diluted

292,804,167

302,885,823

293,564,655

306,278,649